Skip to search formSkip to main contentSkip to account menu

HTLV-I Antibodies

Known as: Human T-Lymphotropic Virus I Antibody, HTLV I Ab, HTLV I Antibodies 
An antibody produced by B lymphocytes in response to human T-cell leukemia virus type 1 infection.
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

Deltaretrovirus AntibodiesImmunologic Factors
HTLV-1 InfectionHTLV-II AntibodiesImmune System ProcessesIn Blood

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps
Background Enterovirus 71 (EV71) is a major causative agent of hand, foot and mouth disease, which has been prevalent in Asia… 
Highly Cited
2011
Highly Cited
2011
The Breadth and Potency of Passively Acquired Human Immunodeficiency Virus Type 1-Specific Neutralizing Antibodies Do Not Correlate with the Risk of Infant Infection
ABSTRACT Although a major goal of human immunodeficiency virus type 1 (HIV-1) vaccine efforts is to elicit broad and potent… 
2003
2003
Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Maternal malaria is associated with the sequestration, in the placenta, of Plasmodium falciparum-infected erythrocytes onto… 
Highly Cited
1998
Highly Cited
1998
Neutralizing Antibodies in Sera from Macaques Infected with Chimeric Simian-Human Immunodeficiency Virus Containing the Envelope Glycoproteins of either a Laboratory-Adapted Variant or a Primary…
ABSTRACT The magnitude and breadth of neutralizing antibodies raised in response to infection with chimeric simian-human… 
Highly Cited
1996
Highly Cited
1996
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
HIV-1 primary infection is characterized by a short high titer viremia, which rapidly declines as the immune response emerges… 
Highly Cited
1992
Highly Cited
1992
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons
The protection of individuals from human immunodeficiency virus type 1 (HIV-1) infection with an envelope subunit derived from a… 
Highly Cited
1992
Highly Cited
1992
Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.
Highly Cited
1991
Highly Cited
1991
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant
The localization of neutralization determinants within the envelope glycoproteins of human immunodeficiency virus (HIV) has been… 
Highly Cited
1987
Highly Cited
1987
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
Sequential serum samples, collected over a 2-3 year follow-up period, of 28 HIV-infected individuals were tested for the presence… 
Highly Cited
1983
Highly Cited
1983
In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
Anti-histone antibodies have been demonstrated in the sera of patients with both idiopathic and drug-induced lupus. We measured… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)